O'Hara Elaine
SEC CIK 1968045 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVAX | NOVAVAX INC | EVP, Chief Strategy Off | 134.6K | — | — | 8 | 2024-03-01 | 2026-03-03 |
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | NVAX | NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Off | F - Tax | $9.49 | -22.4K | 134.6K | -14% | -$212.9K |
| D | 2026-03-05 | 2026-03-03 | NVAX | NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Off | M - OptEx | $0.00 | +56.3K | 157.1K | +56% | $0 |
| DM | 2026-03-03 | 2026-03-01 | NVAX | NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Off | M - OptEx | $0.00 | +59.6K | 77.1K | +341% | $0 |
| DM | 2026-03-03 | 2026-03-01 | NVAX | NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Off | F - Tax | $10.14 | -16.3K | 100.7K | -14% | -$165.7K |
| DM | 2025-03-04 | 2025-03-01 | NVAX | NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Off | M - OptEx | $0.00 | +59.6K | 73.8K | +419% | $0 |
| DM | 2025-03-04 | 2025-03-01 | NVAX | NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Off | F - Tax | $8.33 | -16.3K | 68.5K | -19% | -$136.1K |
| D | 2024-03-05 | 2024-03-01 | NVAX | NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Off | M - OptEx | $5.39 | +19.6K | 19.6K | New | +$105.6K |
| D | 2024-03-05 | 2024-03-01 | NVAX | NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Off | F - Tax | $5.39 | -5,375 | 14.2K | -27% | -$29.0K |
Purchase Sale Sale after option exercise All abbreviations